Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline

This guideline offers recommendations for the management of breast cancer in patients with germline mutations in BRCA1/2, PALB2, CHEK2, and ATM.

Source:

Journal of Clinical Oncology